Publication|Articles|March 14, 2025
- Pharmaceutical Executive: March 2025
- Volume 45
- Issue 2
Pharmaceutical Executive: March 2025 Interactive Digital Edition
View the Pharmaceutical Executive March 2025 issue in an interactive format.
Advertisement
Click
Articles in this issue
10 months ago
High Impact10 months ago
Mark Frohlich: A ‘Natural’ Leader10 months ago
FDA’s New Accelerated Approval Draft GuidanceNewsletter
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk’s Wegovy Pill Becomes First Oral GLP-1 Available in U.S.
2
Parental Control: Why Pharma’s Strongest Asset May Be Its Parent Brand
3
Amgen Acquires Dark Blue Therapeutics in $840 Million Transaction
4
Ketamine’s Regulatory Reckoning: From Rapid Growth to Enforcement
5
